Varian Medical Systems key facts
- Developer of radiation therapy equipment and oncology information systems designed to support cancer diagnosis and treatment.
- Varian Medical Systems’s last known valuation is $16.4B (Apr 2021).
- Notable investors include UPMC Enterprises, Accelmed.
- Status: Acquired/Merged (Operating Subsidiary).
Who backs Varian Medical Systems
2- ·Watch Varian Medical Systems: the Monday email on marks, rounds and moves
Varian Medical Systems funding rounds
No funding rounds for Varian Medical Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Varian Medical Systems valuation
Varian Medical Systems's last known valuation is $16.4 billion, from Apr 2021. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Varian Medical Systems investors
2 investors are on record for Varian Medical Systems, including UPMC Enterprises and Accelmed.
About Varian Medical Systems
Developer of radiation therapy equipment and oncology information systems designed to support cancer diagnosis and treatment. The company offers devices for targeted radiation delivery, imaging, and treatment planning software, enabling healthcare providers and cancer centers to enhance clinical precision, streamline workflows, manage patient data, and improve outcomes for individuals receiving cancer care.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 1948
- Employees
- 9,914
- Website
- varian.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Varian Medical Systems’s last known valuation, Apr 2021. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.